The iRestore Laser Hair Growth System was created in response to the prevalence and psychological impact of hereditary hair loss, which affects two thirds of American men over the age of thirty-five, and forty percent of American women over the age of forty. “Our aim is to provide non-invasive, convenient and effective solutions for people suffering from hair loss,” said Craig Nabat, CEO of Freedom Laser Therapy. “We’re excited to share this study supporting that iRestore can stimulate the regrowth of hair in individuals with androgenic alopecia after 16 weeks of at-home therapy.”
Characterized by thinning on the crown and a receding hairline in men, and a widening part or overall thinning in women, hair loss affects 80 million Americans according to the American Academy of Dermatology. In men, the most common cause is male pattern baldness, while in women hair loss is triggered by a variety of conditions and circumstances. Harnessing light energy from lasers to enhance hair cells’ adenosine triphosphate (ATP) production and the metabolism rate within hair follicles, the iRestore is now shown to counteract androgenetic alopecia in men and women, extending the growth phase of the hair cycle and reactivating dormant hairs.
The subjects of the study were each provided with a test device, unspecified as to active or placebo. Subjects were instructed on the proper use and care of the device and directed to use it at home for 30 minutes every other day, for 16 weeks. The study was developed and directed by a third-party consulting firm, NST Consulting, LLC., and Freedom Laser Therapy had no direct involvement in the research.
For more information about the iRestore Laser Hair Growth System, please visit www.irestorelaser.com.